Familial Nasopharyngeal Carcinoma 6

130 J-C. LinChen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, LinAH, Zeng XF, Ma J (2008) Preliminary results of a prospectiverandomized trial comparing concurrent chemoradiotherapyplus adjuvant chemotherapy with radiotherapyalone in patients with locoregionally advanced nasopharyngealcarcinoma in endemic regions of China. Int J RadiatOncol Biol Phys 71:1356–1364Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen LK, Chu NM, Tan TD,Tsou MH, Huang AT (1998) Prognostic features and treatmentoutcome in locoregionally advanced nasopharyngealcarcinoma following concurrent chemotherapy and radiotherapy.Int J Radiat Oncol Biol Phys 41:755–762Cheng SH, Tsai SY, Yen KL, Jian JJ, Feng AC, Chan KY, Hong CF,Chu NM, Lin YC, Lin CY, Tan TD, Hsieh CY, Chong V, HuangAT (2005) Prognostic significance of parapharyngeal spacevenous plexus and marrow involvement: potential landmarksof dissemination for stage I–III nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys 61:456–465Cheng SH, Tsai SY, Horng CF, Yen KL, Jian JJ, Chan KY, Lin CY,Terng SD, Tsou MH, Chu NM, Chen HH, Chen PL, ChungYL, Hsieh CI, Tan TD, Huang AT (2006a) A prognostic scoringsystem for locoregional control in nasopharyngeal carcinomafollowing conformal radiotherapy. Int J RadiatOncol Biol Phys 66:992–1003Cheng SW, Yang SN, Liang JA, Tsai MH, Shiau AC, Lin FJ (2006b)Value of computed tomography-based tumor volume as apredictor of outcomes in hypopharyngeal cancer aftertreatment with definitive radiotherapy. Laryngoscope 116:2012–2017Chi KH, Chang YC, Guo WY, Leung MJ, Shiau CY, Chen SY,Wang LW, Lai YL, Hsu MM, Lian SL, Chang CH, Liu TW,Chin YH, Yen SH, Perng CH, Chen KY (2002) A phase IIIstudy of adjuvant chemotherapy in advanced nasopharyngealcarcinoma patients. Int J Radiat Oncol Biol Phys52:1238–1244Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS(2001) Serologic markers of Epstein–Barr virus infectionand nasopharyngeal carcinoma in Taiwanese men. N EnglJ Med 345:1877–1882Chong VF, Fan YF, Khoo JBK (1995) Retropharyngeal lymphadenopathyin nasopharyngeal carcinoma. Eur J Radiol21:100–105Chong VF, Mukherji SK, Ng SH, Ginsberg LE, Wee JT, Sham JS,O’Sullivan B (1999) Nasopharyngeal carcinoma: review ofhow imaging affects staging. J Comput Assist Tomogr 23:984–993Chow E, Payne D, O’Sullivan B, Pintilie M, Liu FF, Waldron J,Warde P, Cummings B (2002) Radiotherapy alone inpatients with advanced nasopharyngeal cancer: comparisonwith an intergroup study. Is combined modality treatmentreally necessary? Radiother Oncol 63:269–274Chua DT, Sham JS, Kwong DL, Choy DT, Au GK, Wu PM (1996)Prognostic value of parapharyngeal extension of nasopharyngealcarcinoma. A significant factor in local control anddistant metastasis. Cancer 78:202–210Chua DT, Sham JS, Kwong DL, Au GK, Choy DK (1997a)Retropharyngeal lymphadenopathy in patients withnasopharyngeal carcinoma. A computed tomographybasedstudy. Cancer 79:869–877Chua DT, Sham JS, Kwong DL, Tai KS, Wu PM, Lo M, Yung A,Choy D, Leong L (1997b) Volumetric analysis of tumor extentin nasopharyngeal carcinoma and correlation with treatmentoutcome. Int J Radiat Oncol Biol Phys 39:711–719Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y,Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T,Reksodiputro AH (1998) Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trialcomparing cisplatin and epirubicin followed by radiotherapyversus radiotherapy alone in the treatment of patientswith locoregionally advanced nasopharyngeal carcinoma.Cancer 83:2270–2283Chua DT, Sham JS, Wei WI, Ho WK, Au GK (2001) The predictivevalue of the 1997 American Joint Committee on Cancerstage classification in determining failure patterns innasopharyngeal carcinoma. Cancer 92:2845–2855Chua DT, Sham JS, Choy DT (2004a) Prognostic impact ofhemoglobin levels on treatment outcome in patients withnasopharyngeal carcinoma treated with sequential chemoradiotherapyor radiotherapy alone. Cancer 101:307–316Chua DT, Sham JS, Leung LH, Tai KS, Au GK (2004b) Tumorvolume is not a independent prognostic factor in earlystagenasopharyngeal carcinoma treated by radiotherapyalone. Int J Radiat Oncol Biol Phys 58:1437–1444Chua DT, Nicholls JM, Sham JS, Au GK (2004c) Prognosticvalue of epidermal growth factor receptor expression inpatients with advanced stage nasopharyngeal carcinomatreated with induction chemotherapy and radiotherapy.Int J Radiat Oncol Biol Phys 59:11–20Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM (2004) Impactof magnetic resonance imaging versus CT on nasopharyngealcarcinoma: primary tumor target delineation forradiotherapy. Head Neck 26:241–246Cooper JS, Cohen R, Stevens RE (1998) A comparison of stagingsystems for nasopharyngeal carcinoma. Cancer 83:213–219Corry J, Fisher R, Rischin D, Peters LJ (2006) Relapse patternsin WHO 2/3 nasopharyngeal cancer: is there a differencebetween ethnic Asian vs. non-Asian patients? Int J RadiatOncol Biol Phys 64:63–71Cvitkovic E; the International Nasopharynx Cancer StudyGroup (1996) Preliminary results of a randomized trialcomparing neoadjuvant chemotherapy (cisplatin, epirubicin,bleomycin) plus radiotherapy vs. radiotherapy alone instage IV (³N2, M0) undifferentiated nasopharyngeal carcinoma:a positive effect on progression-free survival. Int JRadiat Oncol Biol Phys 35:463–469Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, RothMS (1994) Sensitive detection of occult breast cancer bythe reverse-transcriptase polymerase chain reaction. J ClinOncol 12:475–482de-Vathaire F, Sancho-Garnier H, de-Thé H, Pieddeloup C,Schwaab G, Ho JH, Ellouz R, Micheau C, Cammoun M,Cachin Y, et al (1988) Prognostic value of EBV markers in theclinical management of nasopharyngeal carcinoma (NPC):a multicenter follow-up study. Int J Cancer 42:176–181Fan H, Nicholls J, Chua D, Chan KH, Sham J, Lee S, GulleyML (2004) Laboratory markers of tumor burden innasopharyngeal carcinoma: a comparison of viral loadand serologic tests for Epstein–Barr virus. Int J Cancer112:1036–1041Fang FM, Leung SW, Wang CJ, Su CY, Lui CC, Chen HC, Sun M,Lin TM (1999) Computed tomography findings of bonyregeneration after radiotherapy for nasopharyngeal carcinomawith skull base destruction: implications for localcontrol. Int J Radiat Oncol Biol Phys 44:305–309Fang FM, Tsai WL, Go SF, Ho MW, Wu JM, Wang CJ, Su CY,Chen WC, Huang EY (2001) Implications of quantitative